UNICA IRIS Institutional Research Information System

TRONCI, ELISABETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 83.156
NA - Nord America 3.680
AS - Asia 1.335
SA - Sud America 197
AF - Africa 37
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 88.411
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 82.260
US - Stati Uniti d'America 3.626
SG - Singapore 529
CN - Cina 455
UA - Ucraina 238
DE - Germania 203
SE - Svezia 169
BR - Brasile 158
VN - Vietnam 113
FI - Finlandia 81
GB - Regno Unito 69
FR - Francia 61
HK - Hong Kong 50
KR - Corea 41
IN - India 37
CA - Canada 33
RU - Federazione Russa 22
IQ - Iraq 20
AR - Argentina 18
BD - Bangladesh 16
JP - Giappone 13
BE - Belgio 11
MX - Messico 10
NL - Olanda 10
PK - Pakistan 10
ZA - Sudafrica 10
CZ - Repubblica Ceca 8
ID - Indonesia 8
KE - Kenya 8
CL - Cile 7
ES - Italia 7
TR - Turchia 7
AE - Emirati Arabi Uniti 6
SA - Arabia Saudita 6
EG - Egitto 5
EC - Ecuador 4
MA - Marocco 4
PL - Polonia 4
TH - Thailandia 4
EU - Europa 3
JM - Giamaica 3
MY - Malesia 3
PY - Paraguay 3
TN - Tunisia 3
VE - Venezuela 3
AU - Australia 2
BG - Bulgaria 2
CO - Colombia 2
DZ - Algeria 2
GT - Guatemala 2
IE - Irlanda 2
JO - Giordania 2
KH - Cambogia 2
KZ - Kazakistan 2
NI - Nicaragua 2
SN - Senegal 2
AM - Armenia 1
AO - Angola 1
AT - Austria 1
AZ - Azerbaigian 1
BB - Barbados 1
BO - Bolivia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DK - Danimarca 1
GE - Georgia 1
HN - Honduras 1
IL - Israele 1
KG - Kirghizistan 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
LY - Libia 1
MN - Mongolia 1
MT - Malta 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
RO - Romania 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 88.411
Salva come PNG Salva come JPEG
Città #
Cagliari 78.732
Uta 3.352
Fairfield 409
Woodbridge 345
Ashburn 330
Singapore 258
Chandler 203
Ann Arbor 200
San Jose 186
Houston 178
Wilmington 175
Seattle 149
Cambridge 146
Jacksonville 122
Nyköping 121
Boardman 115
Beijing 112
Dallas 110
Dearborn 101
Los Angeles 53
Shanghai 53
Nanjing 51
Santa Clara 48
Hong Kong 43
Ho Chi Minh City 42
The Dalles 41
Helsinki 39
New York 39
Seoul 38
Lauterbourg 36
Council Bluffs 30
Milan 25
Boston 22
Hefei 22
San Diego 22
Hanoi 20
Guangzhou 14
Munich 14
Buffalo 13
Dong Ket 12
São Paulo 12
Tianjin 12
Tokyo 12
Brussels 11
Changsha 11
Redwood City 11
Shenyang 11
Frankfurt am Main 10
Mountain View 10
Nanchang 10
Toronto 10
Verona 10
Sassari 9
Brooklyn 8
Hebei 8
London 8
Montreal 8
Norwalk 8
Orem 8
Phoenix 8
Redondo Beach 8
Baghdad 7
Chennai 7
Falls Church 7
Hangzhou 7
Nairobi 7
New Delhi 7
Turku 7
Washington 7
Brno 6
Da Nang 6
Jinan 6
Johannesburg 6
Oristano 6
Padova 6
Rome 6
San Francisco 6
Central 5
Stockholm 5
Ankara 4
Atlanta 4
Detroit 4
Florence 4
Grottammare 4
Jiaxing 4
Lahore 4
Orange 4
Pune 4
Zhengzhou 4
Amsterdam 3
Belo Horizonte 3
Betim 3
Biên Hòa 3
Borås 3
Brasília 3
Camaçari 3
Casablanca 3
Chicago 3
Clifton 3
Columbus 3
Totale 86.411
Salva come PNG Salva come JPEG
Nome #
5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction 5.828
Effect of memantine on L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson's disease. 4.338
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease 4.296
The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease 4.083
Anti-dyskinetic effect of anpirtoline in animal models of L-DOPA-induced dyskinesia 3.694
Effect of selective and non-selective serotonin receptor activation on l-DOPA-induced therapeutic efficacy and dyskinesia in parkinsonian rats 3.583
Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease 3.551
The anti-dyskinetic effect of dopamine receptor blockade is enhanced in parkinsonian rats following dopamine neuron transplantation 3.469
null 2.940
Vitamin A deficiency induces motor impairments and striatal cholinergic dysfunction in rats 2.875
Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia 2.588
The serotonergic system in levodopa-induced dyskinesia 2.566
Efficacy and safety of 5-Hydroxytryptophan on levodopa-induced motor complications in Parkinson's disease: A preliminary finding 2.368
null 2.298
5-HT1 receptor agonists for the treatment of L-DOPA-induced dyskinesia: From animal models to clinical investigation 2.249
null 2.247
Foetal cell transplantation for Parkinson's disease: focus on graft-induced dyskinesia 2.196
Serotonin system implication in L-DOPA-induced dyskinesia: from animal models to clinical investigations 2.178
Role of serotonin neurons in L-DOPA- and graft-induced dyskinesia in a rat model of parkinson's disease 2.175
Amphetamine-induced rotation and L-DOPA-induced dyskinesia in the rat 6-OHDA model: A correlation study 2.164
A new ethyladenine antagonist of adenosine A(2A) receptors: behavioral and biochemical characterization as an antiparkinsonian drug 2.113
Caffeine consumption and changes in the function of dopaminergic transmission: evidence of a hyperdopaminergic state in rats subchronically treated with caffeine 1.798
Serotonin neuron-dependent and -independent reduction of dyskinesia by 5-HT1A and5-HT1B receptor agonists in the rat Parkinson model 1.552
null 1.471
BDNF Overexpression Increases Striatal D3Receptor Level at Striatal Neurons and Exacerbates D1-Receptor Agonist-Induced Dyskinesia 1.413
Long-term increase in GAD67 mRNA expression in the central amygdala of rats sensitized by drugs and stress 1.317
Characterization of the antiparkinsonian effects of the new adenosine A2A receptor antagonist ST1535: acute and subchronic studies in rats 1.290
Caffeine sensitization and cross-sensitization with amphetamine: association to post-synaptic changes in rat striatal neurons 1.249
Adenosine A2A and dopamine receptor interactions in basal ganglia of dopamine denervated rats 1.177
Dopamine and adenosine receptor interaction as the basis for the treatment of Parkinson's disease 1.122
Effect of serotonin transporter blockade on L-DOPA-induced dyskinesia in animal models of Parkinson's disease 1.093
Modulation of serotonergic transmission by eltoprazine in L-DOPA-induced dyskinesia: Behavioral, molecular, and synaptic mechanisms 1.090
Dopamine and adenosine receptor interaction as basis for the treatment of Parkinson's disease 1.077
CAFFEINE SESITIZATION AND CROSS-SENSITIZATION WITH AMPHETAMINE: ASSOCIATION TO POST-SYNAPTIC CHANGES IN RAT STRIATAL NEURONS 1.055
CAFFEINE SENSITIZATION AND CROSS-SENSITIZATION WITH AMPHETAMINE: ASSOCIATION TO POST BUT NOT PRE-SYNAPTIC CHANGES IN RAT STRIATAL NEURON 1.048
null 1.012
Changes in the expression of tonic and phasic neurochemical markers of activity in a rat model of L-DOPA induced dyskinesia 983
null 967
Changes in the expression of tonic and phasic neurochemical markers of activity in a rat model of L-DOPA induced dynskinesia 960
Selective modifications in GAD67 mRNA levels in striatonigral and striatopallidal pathways correlate to dopamine agonist priming in 6-hydroxydopamine-lesioned rats 929
Different responsiveness of striatonigral and striatopallidal neurons to L-DOPA after a subchronic intermittent L-DOPA treatment 877
BDNF over-expression induces striatal serotonin fiber sprouting and increases the susceptibility to L-DOPA-induced dyskinesia in 6-OHDA-lesioned rats 702
Potentiation of amphetamine-mediated responses in caffeine-sensitized rats involves modifications in A2A receptors and zif-268 mRNAs in striatal neurons 322
Subchronic-intermittent caffeine amplifies the motor effects of amphetamine in rats 283
Totale 88.586
Salva come PNG Salva come JPEG
Categoria #
all - tutte 105.719
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 105.719
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021577 0 0 0 0 0 0 0 0 0 0 0 577
2021/20223.547 385 362 170 179 252 269 204 158 268 423 488 389
2022/20235.204 349 569 563 435 460 580 293 349 389 406 545 266
2023/20245.597 227 174 225 283 508 834 880 378 214 395 604 875
2024/202516.813 4.751 4.481 4.113 1.153 579 619 676 52 124 73 89 103
2025/20262.603 186 93 249 214 182 170 695 131 173 268 161 81
Totale 88.586